All autopsies

// STARTUP COMPARISON

Theranos vs WeWork

Theranos failed in 2018 due to Fraud. WeWork failed in 2023 due to Founder Chaos. Different causes, different sectors, different eras — but the same simulation outcome.

METRIC🔥 Theranos🔥 WeWork
SectorBiotechReal Estate
CountryUSAUSA
Founded20032010
Died20182023
Raised$945M$16B
Peak$9B valuation$47B valuation
Primary CauseFraudFounder Chaos
Flame %🔥 98%🔥 95%

// WHY EACH FAILED

🔥 Theranos
Fraud
Theranos failed because its Edison blood-testing device never worked. The company raised $945M while falsifying results using conventional machines. A 2015 Wall Street Journal investigation by John Carreyrou exposed the fraud. Elizabeth Holmes was convicted in January 2022 and sentenced to 11 years in prison.
// LESSON
The product must work. "Fake it till you make it" ends at the FDA boundary. No amount of narrative replaces a working device.
🔥 WeWork
Founder Chaos
WeWork's 2019 IPO collapsed when its S-1 revealed $1.9B in losses on $1.8B revenue, a 29x valuation-to-revenue multiple, and Adam Neumann's erratic governance — including charging the company $5.9M for the trademark "We". SoftBank lost $14B. WeWork filed Chapter 11 in November 2023.
// LESSON
A real estate company with yoga is still a real estate company. Narrative premium has a ceiling. The market finds it during IPO due diligence.

// IN THE SIMULATION

In UnicornBurn Season 0, Theranos triggers PRODUCT_VALIDATION_FAILURE before reaching Seed round. The simulation validates product claims before unlocking funding rounds — unlike Theranos investors.

WeWork maxes out the NARRATIVE_PREMIUM variable then crashes to zero at IPO_ATTEMPT. The simulation caps narrative premium at 3x revenue. 29x triggers a hard correction event.

// EXPLORE FURTHER